₹ 1,622.31 Cr
0.21%
NIFTY Pharma TRI
INF204KC1089
1000.0
0.0
100
Jitendra Tolani
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Nippon India Nifty Pharma ETF | 14.92 | 20.8 | 13.69 |
| Nifty Pharma TRI | 15.1 | 21.13 | 13.97 |
Equity
Debt
Others
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 21.42 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.53 |
| Dr. Reddys Laboratories Ltd | 8.93 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 8.86 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 6.18 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 5.96 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 5.19 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.48 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.85 |
| ALKEM LABORATORIES LIMITED EQ | 3.62 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.95 |
| Scheme Name | 5Y (%) |
|---|---|
| Nippon India Nifty Pharma ETF | 13.69 |
| Tata Silver ETF | 0.0 |
| ICICI Pru Silver ETF | 0.0 |
| ABSL Silver ETF | 0.0 |
| DSP Silver ETF | 0.0 |
| Kotak Silver ETF | 0.0 |
| SBI Silver ETF | 0.0 |
| Axis Silver ETF | 0.0 |
| Mirae Asset Silver ETF | 0.0 |
| Nippon India Silver ETF | 0.0 |